Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Meningeal Neoplasms | 33 | 2024 | 1248 | 5.460 |
Why?
|
Meningioma | 32 | 2023 | 1218 | 5.130 |
Why?
|
Craniopharyngioma | 12 | 2024 | 276 | 3.330 |
Why?
|
Pituitary Neoplasms | 18 | 2024 | 1323 | 2.660 |
Why?
|
Homeodomain Proteins | 15 | 2021 | 2418 | 1.620 |
Why?
|
Brain Neoplasms | 40 | 2024 | 9032 | 1.610 |
Why?
|
Proto-Oncogene Proteins B-raf | 12 | 2024 | 2057 | 1.490 |
Why?
|
Glioma | 21 | 2024 | 3455 | 1.370 |
Why?
|
Rhabdoid Tumor | 2 | 2024 | 210 | 1.260 |
Why?
|
Fluorescent Antibody Technique | 5 | 2023 | 2467 | 1.160 |
Why?
|
Ubiquitin Thiolesterase | 5 | 2023 | 455 | 1.120 |
Why?
|
Cerebellar Neoplasms | 5 | 2024 | 586 | 1.100 |
Why?
|
Transcription Factors | 18 | 2021 | 12130 | 1.070 |
Why?
|
Central Nervous System Neoplasms | 4 | 2024 | 916 | 1.020 |
Why?
|
Glioblastoma | 10 | 2024 | 3483 | 1.020 |
Why?
|
Cilia | 3 | 2024 | 495 | 0.930 |
Why?
|
Pineal Gland | 3 | 2018 | 158 | 0.890 |
Why?
|
Heat-Shock Proteins | 3 | 2020 | 795 | 0.880 |
Why?
|
DNA-Binding Proteins | 24 | 2020 | 9610 | 0.870 |
Why?
|
Astrocytoma | 6 | 2014 | 775 | 0.790 |
Why?
|
Mutation | 43 | 2024 | 30053 | 0.780 |
Why?
|
Forkhead Transcription Factors | 3 | 2017 | 1616 | 0.740 |
Why?
|
Pinealoma | 2 | 2018 | 52 | 0.730 |
Why?
|
Tumor Microenvironment | 15 | 2024 | 3878 | 0.700 |
Why?
|
Tumor Suppressor Proteins | 6 | 2020 | 2805 | 0.690 |
Why?
|
Neoplasms | 22 | 2023 | 22173 | 0.660 |
Why?
|
Palatine Tonsil | 1 | 2019 | 193 | 0.650 |
Why?
|
Single-Cell Analysis | 7 | 2024 | 2451 | 0.650 |
Why?
|
Central Nervous System Cysts | 2 | 2016 | 56 | 0.640 |
Why?
|
Medulloblastoma | 6 | 2019 | 678 | 0.640 |
Why?
|
Immunoconjugates | 2 | 2024 | 953 | 0.640 |
Why?
|
Heat-Shock Response | 3 | 2020 | 179 | 0.620 |
Why?
|
Skull Base Neoplasms | 1 | 2021 | 270 | 0.610 |
Why?
|
Gastrointestinal Stromal Tumors | 2 | 2021 | 617 | 0.600 |
Why?
|
Cell Nucleus | 8 | 2024 | 2910 | 0.600 |
Why?
|
Glutarates | 2 | 2022 | 243 | 0.590 |
Why?
|
Neoplasm Recurrence, Local | 15 | 2023 | 9280 | 0.590 |
Why?
|
Genomics | 14 | 2024 | 5821 | 0.560 |
Why?
|
Gene Expression Regulation, Neoplastic | 15 | 2021 | 8554 | 0.550 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2021 | 954 | 0.530 |
Why?
|
Breast Neoplasms | 13 | 2024 | 21019 | 0.530 |
Why?
|
Choroid Plexus Neoplasms | 1 | 2016 | 38 | 0.530 |
Why?
|
Humans | 186 | 2024 | 761596 | 0.520 |
Why?
|
Trans-Activators | 3 | 2017 | 2856 | 0.520 |
Why?
|
Antineoplastic Agents | 15 | 2024 | 13642 | 0.520 |
Why?
|
Neurofibromatosis 2 | 1 | 2019 | 385 | 0.510 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 1136 | 0.500 |
Why?
|
Axonemal Dyneins | 1 | 2014 | 25 | 0.490 |
Why?
|
Comparative Genomic Hybridization | 9 | 2017 | 473 | 0.480 |
Why?
|
Recombination, Genetic | 8 | 2001 | 1519 | 0.480 |
Why?
|
Genes, RAG-1 | 6 | 2001 | 67 | 0.480 |
Why?
|
Central Nervous System Diseases | 1 | 2019 | 520 | 0.480 |
Why?
|
Xanthomatosis | 1 | 2014 | 32 | 0.470 |
Why?
|
Biology | 1 | 2016 | 290 | 0.470 |
Why?
|
Lung Neoplasms | 8 | 2024 | 13381 | 0.470 |
Why?
|
Telomerase | 5 | 2024 | 745 | 0.460 |
Why?
|
Solitary Fibrous Tumors | 3 | 2024 | 67 | 0.460 |
Why?
|
Cell Lineage | 4 | 2019 | 2557 | 0.460 |
Why?
|
Mass Spectrometry | 4 | 2019 | 2192 | 0.460 |
Why?
|
Brain Edema | 1 | 2018 | 604 | 0.460 |
Why?
|
Germinoma | 2 | 2022 | 132 | 0.460 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2014 | 386 | 0.430 |
Why?
|
Image Processing, Computer-Assisted | 7 | 2024 | 9001 | 0.430 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 1301 | 0.420 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 5 | 2015 | 266 | 0.420 |
Why?
|
Ependymoma | 1 | 2016 | 320 | 0.420 |
Why?
|
Stromal Cells | 1 | 2018 | 1330 | 0.410 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 5 | 2023 | 506 | 0.410 |
Why?
|
Antibodies | 2 | 2019 | 2418 | 0.410 |
Why?
|
Protein Biosynthesis | 2 | 2013 | 2112 | 0.400 |
Why?
|
Immunotherapy | 5 | 2023 | 4652 | 0.400 |
Why?
|
Patient Care | 1 | 2017 | 622 | 0.390 |
Why?
|
DNA Nucleotidyltransferases | 3 | 2001 | 175 | 0.390 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1667 | 0.370 |
Why?
|
Point Mutation | 2 | 2015 | 1595 | 0.370 |
Why?
|
Cell Line, Tumor | 20 | 2024 | 16990 | 0.360 |
Why?
|
Intraoperative Care | 1 | 2014 | 767 | 0.350 |
Why?
|
Computer Graphics | 2 | 2022 | 340 | 0.350 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 785 | 0.350 |
Why?
|
DNA Copy Number Variations | 7 | 2020 | 2020 | 0.340 |
Why?
|
Proto-Oncogene Proteins c-akt | 7 | 2024 | 2457 | 0.340 |
Why?
|
Ribosomes | 1 | 2013 | 501 | 0.340 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 2022 | 491 | 0.340 |
Why?
|
HSP90 Heat-Shock Proteins | 4 | 2019 | 424 | 0.340 |
Why?
|
Software | 6 | 2024 | 4434 | 0.340 |
Why?
|
Nuclear Proteins | 12 | 2018 | 5799 | 0.330 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2023 | 4580 | 0.330 |
Why?
|
Paraffin Embedding | 3 | 2019 | 302 | 0.330 |
Why?
|
Epitopes | 2 | 2021 | 2503 | 0.330 |
Why?
|
Spinal Cord Neoplasms | 2 | 2014 | 263 | 0.330 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2011 | 718 | 0.320 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2015 | 1092 | 0.320 |
Why?
|
Formaldehyde | 3 | 2019 | 358 | 0.320 |
Why?
|
Cell Cycle | 4 | 2022 | 2932 | 0.300 |
Why?
|
Chromosome Aberrations | 1 | 2014 | 1768 | 0.300 |
Why?
|
Retinal Neoplasms | 1 | 2009 | 146 | 0.290 |
Why?
|
Mice | 33 | 2024 | 81539 | 0.290 |
Why?
|
Breast | 3 | 2022 | 1967 | 0.290 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2016 | 2865 | 0.280 |
Why?
|
Leiomyosarcoma | 2 | 2024 | 422 | 0.280 |
Why?
|
Epithelial Cells | 3 | 2024 | 3677 | 0.280 |
Why?
|
Immunohistochemistry | 10 | 2019 | 11076 | 0.280 |
Why?
|
Molecular Chaperones | 4 | 2020 | 754 | 0.280 |
Why?
|
DNA Mutational Analysis | 7 | 2020 | 4111 | 0.280 |
Why?
|
Immunologic Deficiency Syndromes | 2 | 2000 | 547 | 0.270 |
Why?
|
Adenoma | 4 | 2020 | 2163 | 0.270 |
Why?
|
Prognosis | 16 | 2024 | 29629 | 0.270 |
Why?
|
Animals | 48 | 2024 | 168475 | 0.260 |
Why?
|
Indoles | 1 | 2014 | 1833 | 0.260 |
Why?
|
Cell Differentiation | 7 | 2024 | 11530 | 0.260 |
Why?
|
Cell Proliferation | 7 | 2022 | 10451 | 0.260 |
Why?
|
Proteins | 7 | 2020 | 6032 | 0.250 |
Why?
|
Valine | 3 | 2015 | 408 | 0.240 |
Why?
|
Tumor Cells, Cultured | 4 | 2021 | 6131 | 0.240 |
Why?
|
Protein Kinase Inhibitors | 6 | 2024 | 5672 | 0.240 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 1745 | 0.240 |
Why?
|
Sulfonamides | 1 | 2014 | 1979 | 0.230 |
Why?
|
Histones | 4 | 2023 | 2580 | 0.230 |
Why?
|
Neuroma | 1 | 2006 | 133 | 0.230 |
Why?
|
Severe Combined Immunodeficiency | 4 | 2001 | 227 | 0.230 |
Why?
|
Stathmin | 1 | 2024 | 70 | 0.230 |
Why?
|
Vestibular Diseases | 1 | 2006 | 231 | 0.230 |
Why?
|
STAT6 Transcription Factor | 1 | 2024 | 194 | 0.220 |
Why?
|
Molecular Sequence Data | 13 | 2015 | 17635 | 0.220 |
Why?
|
Tissue Array Analysis | 2 | 2018 | 550 | 0.220 |
Why?
|
Molecular Imaging | 3 | 2016 | 815 | 0.220 |
Why?
|
Claudins | 1 | 2024 | 117 | 0.210 |
Why?
|
Survival Rate | 7 | 2021 | 12723 | 0.210 |
Why?
|
Female | 55 | 2024 | 392705 | 0.210 |
Why?
|
Ketones | 1 | 2024 | 184 | 0.210 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2007 | 549 | 0.210 |
Why?
|
Disease Progression | 8 | 2023 | 13510 | 0.210 |
Why?
|
Furans | 1 | 2024 | 202 | 0.210 |
Why?
|
Spectrum Analysis, Raman | 2 | 2016 | 237 | 0.210 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2024 | 3605 | 0.210 |
Why?
|
T-Lymphocytes | 3 | 2018 | 10194 | 0.200 |
Why?
|
Choriocarcinoma | 1 | 2022 | 121 | 0.200 |
Why?
|
Isocitrate Dehydrogenase | 4 | 2022 | 938 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2020 | 2827 | 0.190 |
Why?
|
Quality Control | 1 | 2024 | 832 | 0.190 |
Why?
|
Hemangiosarcoma | 1 | 2024 | 215 | 0.190 |
Why?
|
Circadian Clocks | 1 | 2024 | 164 | 0.190 |
Why?
|
Repressor Proteins | 3 | 2024 | 2986 | 0.190 |
Why?
|
Apoptosis | 6 | 2023 | 9490 | 0.190 |
Why?
|
Oncogenes | 4 | 2023 | 1222 | 0.190 |
Why?
|
Molecular Targeted Therapy | 5 | 2021 | 2811 | 0.190 |
Why?
|
Neurofibromin 2 | 5 | 2023 | 271 | 0.190 |
Why?
|
Neurilemmoma | 1 | 2006 | 526 | 0.190 |
Why?
|
Sarcoidosis | 1 | 2007 | 521 | 0.190 |
Why?
|
Liposarcoma | 1 | 2024 | 289 | 0.190 |
Why?
|
5'-Nucleotidase | 1 | 2022 | 161 | 0.190 |
Why?
|
Receptors, CCR | 1 | 2021 | 37 | 0.190 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2015 | 3080 | 0.190 |
Why?
|
Glutamic Acid | 3 | 2015 | 1176 | 0.180 |
Why?
|
Phosphatidylinositol 4,5-Diphosphate | 1 | 2001 | 124 | 0.180 |
Why?
|
Pyridones | 2 | 2024 | 809 | 0.180 |
Why?
|
Isoenzymes | 2 | 2006 | 1687 | 0.180 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 1 | 2001 | 94 | 0.180 |
Why?
|
Male | 51 | 2024 | 360846 | 0.180 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2021 | 350 | 0.180 |
Why?
|
Citric Acid Cycle | 1 | 2022 | 231 | 0.180 |
Why?
|
Ecosystem | 2 | 2022 | 490 | 0.180 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2021 | 174 | 0.180 |
Why?
|
Type C Phospholipases | 1 | 2001 | 287 | 0.180 |
Why?
|
Base Sequence | 8 | 2014 | 12441 | 0.180 |
Why?
|
Tubulin | 1 | 2024 | 693 | 0.180 |
Why?
|
Radiotherapy | 1 | 2007 | 1498 | 0.170 |
Why?
|
Middle Aged | 33 | 2024 | 220921 | 0.170 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2022 | 3639 | 0.170 |
Why?
|
Diagnostic Imaging | 5 | 2023 | 3530 | 0.170 |
Why?
|
Phase Transition | 1 | 2020 | 71 | 0.170 |
Why?
|
Pharmaceutical Preparations | 2 | 2022 | 1089 | 0.170 |
Why?
|
Proteomics | 4 | 2024 | 3848 | 0.170 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2016 | 1321 | 0.170 |
Why?
|
Child | 18 | 2024 | 80158 | 0.170 |
Why?
|
Germ-Line Mutation | 2 | 2018 | 1858 | 0.170 |
Why?
|
Ovarian Neoplasms | 3 | 2022 | 4878 | 0.170 |
Why?
|
Nitriles | 1 | 2024 | 971 | 0.170 |
Why?
|
Copper | 1 | 2022 | 369 | 0.160 |
Why?
|
Gene Expression Profiling | 9 | 2023 | 9420 | 0.160 |
Why?
|
Co-Repressor Proteins | 1 | 2020 | 190 | 0.160 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 3 | 2021 | 899 | 0.160 |
Why?
|
Clone Cells | 1 | 2022 | 1659 | 0.160 |
Why?
|
Young Adult | 15 | 2024 | 59260 | 0.160 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3801 | 0.160 |
Why?
|
Frameshift Mutation | 1 | 2000 | 392 | 0.160 |
Why?
|
Receptors, Prostaglandin | 1 | 2018 | 53 | 0.160 |
Why?
|
Intercellular Signaling Peptides and Proteins | 4 | 2017 | 1651 | 0.160 |
Why?
|
Retina | 1 | 2009 | 2659 | 0.160 |
Why?
|
Tissue Fixation | 1 | 2019 | 241 | 0.160 |
Why?
|
Hemangiopericytoma | 1 | 2018 | 71 | 0.160 |
Why?
|
Antigens, Neoplasm | 3 | 2021 | 1993 | 0.150 |
Why?
|
Monitoring, Intraoperative | 2 | 2016 | 942 | 0.150 |
Why?
|
Signal Transduction | 7 | 2021 | 23447 | 0.150 |
Why?
|
Adult | 31 | 2024 | 221210 | 0.150 |
Why?
|
Methionine | 1 | 2000 | 572 | 0.150 |
Why?
|
Disease Management | 3 | 2018 | 2508 | 0.150 |
Why?
|
BRCA1 Protein | 2 | 2022 | 1158 | 0.150 |
Why?
|
Oligodendroglioma | 3 | 2014 | 279 | 0.150 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4576 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 11 | 2018 | 36426 | 0.150 |
Why?
|
Gene Dosage | 3 | 2017 | 1218 | 0.150 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9177 | 0.150 |
Why?
|
Amino Acid Sequence | 9 | 2024 | 13446 | 0.150 |
Why?
|
Microscopy | 3 | 2022 | 903 | 0.150 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2539 | 0.140 |
Why?
|
Adenosine | 1 | 2022 | 808 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2020 | 11742 | 0.140 |
Why?
|
Artifacts | 2 | 2024 | 1911 | 0.140 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2022 | 478 | 0.140 |
Why?
|
Withanolides | 2 | 2014 | 10 | 0.140 |
Why?
|
HMGB Proteins | 2 | 2007 | 45 | 0.140 |
Why?
|
Azepines | 1 | 2019 | 329 | 0.140 |
Why?
|
Dystrophin | 1 | 2018 | 283 | 0.140 |
Why?
|
Obesity | 2 | 2018 | 12947 | 0.140 |
Why?
|
Immunity | 1 | 2023 | 996 | 0.140 |
Why?
|
Receptors, Leptin | 1 | 2018 | 350 | 0.140 |
Why?
|
BRCA2 Protein | 1 | 2022 | 805 | 0.140 |
Why?
|
DNA Methylation | 5 | 2024 | 4399 | 0.140 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 592 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 3 | 2024 | 641 | 0.130 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2018 | 457 | 0.130 |
Why?
|
Oncogene Proteins v-myb | 1 | 2016 | 25 | 0.130 |
Why?
|
Ependyma | 1 | 2016 | 56 | 0.130 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2018 | 245 | 0.130 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2023 | 2872 | 0.130 |
Why?
|
Endocrine Gland Neoplasms | 1 | 2015 | 23 | 0.130 |
Why?
|
Octamer Transcription Factor-3 | 2 | 2007 | 223 | 0.130 |
Why?
|
Progestins | 1 | 2018 | 301 | 0.130 |
Why?
|
Follow-Up Studies | 6 | 2021 | 39106 | 0.130 |
Why?
|
Gene Rearrangement | 2 | 2016 | 1125 | 0.130 |
Why?
|
Pituitary Gland | 2 | 2015 | 635 | 0.130 |
Why?
|
Orbital Neoplasms | 1 | 2017 | 222 | 0.130 |
Why?
|
Neoplasm Metastasis | 3 | 2020 | 4915 | 0.130 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2016 | 1609 | 0.130 |
Why?
|
Adolescent | 16 | 2024 | 88326 | 0.130 |
Why?
|
Neoplasm Transplantation | 3 | 2014 | 2016 | 0.130 |
Why?
|
Survival Analysis | 4 | 2021 | 10090 | 0.120 |
Why?
|
Diagnosis, Differential | 8 | 2018 | 12973 | 0.120 |
Why?
|
Neoplasm Proteins | 3 | 2018 | 3617 | 0.120 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2022 | 926 | 0.120 |
Why?
|
SOXB1 Transcription Factors | 2 | 2007 | 286 | 0.120 |
Why?
|
Arginine Vasopressin | 1 | 2015 | 125 | 0.120 |
Why?
|
RNA, Messenger | 6 | 2018 | 12794 | 0.120 |
Why?
|
Cell Survival | 3 | 2020 | 5791 | 0.120 |
Why?
|
Adenosine Triphosphatases | 1 | 1999 | 836 | 0.120 |
Why?
|
NF-kappa B | 1 | 2023 | 2490 | 0.120 |
Why?
|
Drug Administration Schedule | 4 | 2019 | 4853 | 0.120 |
Why?
|
Soft Tissue Neoplasms | 1 | 2023 | 1159 | 0.120 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2023 | 1728 | 0.120 |
Why?
|
NIH 3T3 Cells | 2 | 2013 | 670 | 0.120 |
Why?
|
Chromosomes, Human | 1 | 2016 | 441 | 0.120 |
Why?
|
Hemangioblastoma | 1 | 2014 | 62 | 0.120 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5368 | 0.120 |
Why?
|
Neoplasm Staging | 4 | 2018 | 11120 | 0.120 |
Why?
|
Melanoma | 2 | 2024 | 5709 | 0.120 |
Why?
|
Poxviridae Infections | 1 | 2014 | 12 | 0.120 |
Why?
|
Orthopoxvirus | 1 | 2014 | 11 | 0.120 |
Why?
|
Sequence Analysis, DNA | 5 | 2020 | 4740 | 0.110 |
Why?
|
Gene Deletion | 2 | 2018 | 2665 | 0.110 |
Why?
|
RNA | 1 | 2024 | 2725 | 0.110 |
Why?
|
Colorectal Neoplasms | 2 | 2024 | 6938 | 0.110 |
Why?
|
Quinolines | 1 | 2019 | 765 | 0.110 |
Why?
|
Phenotype | 6 | 2021 | 16592 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2021 | 5305 | 0.110 |
Why?
|
Aged | 23 | 2024 | 169310 | 0.110 |
Why?
|
Neuronavigation | 1 | 2015 | 166 | 0.110 |
Why?
|
Computer Systems | 1 | 2015 | 470 | 0.110 |
Why?
|
Fatal Outcome | 1 | 2018 | 1835 | 0.110 |
Why?
|
Triazoles | 1 | 2019 | 903 | 0.110 |
Why?
|
Small Molecule Libraries | 1 | 2019 | 733 | 0.110 |
Why?
|
Telomere | 1 | 2020 | 943 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2015 | 2510 | 0.110 |
Why?
|
Semantics | 1 | 2017 | 613 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 5314 | 0.110 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2015 | 618 | 0.110 |
Why?
|
Intermediate Filaments | 1 | 2014 | 172 | 0.110 |
Why?
|
Gene Targeting | 1 | 2016 | 838 | 0.110 |
Why?
|
Encephalomyelitis, Eastern Equine | 1 | 2013 | 14 | 0.110 |
Why?
|
Protein Structure, Tertiary | 5 | 2013 | 3792 | 0.110 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 305 | 0.110 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2015 | 629 | 0.110 |
Why?
|
Nuclear Localization Signals | 2 | 2024 | 77 | 0.100 |
Why?
|
Sarcoma | 1 | 2024 | 1801 | 0.100 |
Why?
|
Benzofurans | 1 | 2013 | 139 | 0.100 |
Why?
|
Genotype | 8 | 2022 | 12990 | 0.100 |
Why?
|
Neurogenesis | 1 | 2019 | 863 | 0.100 |
Why?
|
Cross Reactions | 1 | 2014 | 817 | 0.100 |
Why?
|
Breast Neoplasms, Male | 1 | 2014 | 219 | 0.100 |
Why?
|
Promoter Regions, Genetic | 4 | 2020 | 5790 | 0.100 |
Why?
|
Histocytochemistry | 1 | 2013 | 698 | 0.100 |
Why?
|
Lipids | 3 | 2014 | 3341 | 0.100 |
Why?
|
beta Catenin | 2 | 2016 | 1040 | 0.100 |
Why?
|
Genes, Neurofibromatosis 1 | 1 | 2012 | 74 | 0.100 |
Why?
|
Awards and Prizes | 1 | 2016 | 360 | 0.100 |
Why?
|
DNA | 4 | 2001 | 7213 | 0.100 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 1410 | 0.100 |
Why?
|
Aged, 80 and over | 12 | 2024 | 58984 | 0.100 |
Why?
|
DNA Fragmentation | 1 | 2012 | 237 | 0.100 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1704 | 0.100 |
Why?
|
Host-Parasite Interactions | 1 | 2014 | 300 | 0.100 |
Why?
|
Embryonic Stem Cells | 2 | 2010 | 1263 | 0.090 |
Why?
|
Bayes Theorem | 2 | 2023 | 2330 | 0.090 |
Why?
|
Receptors, Calcitriol | 1 | 2014 | 360 | 0.090 |
Why?
|
Drug Eruptions | 1 | 2014 | 335 | 0.090 |
Why?
|
MAP Kinase Signaling System | 2 | 2015 | 1486 | 0.090 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2020 | 617 | 0.090 |
Why?
|
Algorithms | 5 | 2022 | 14033 | 0.090 |
Why?
|
Sclerosis | 1 | 2011 | 210 | 0.090 |
Why?
|
Cohort Studies | 8 | 2022 | 41495 | 0.090 |
Why?
|
Microscopy, Fluorescence | 1 | 2018 | 2645 | 0.090 |
Why?
|
Neurofibromin 1 | 1 | 2012 | 190 | 0.090 |
Why?
|
Myelin P0 Protein | 1 | 2010 | 15 | 0.090 |
Why?
|
Nucleic Acid Denaturation | 1 | 2011 | 110 | 0.090 |
Why?
|
Frozen Sections | 1 | 2011 | 153 | 0.090 |
Why?
|
Blood-Brain Barrier | 2 | 2016 | 1027 | 0.090 |
Why?
|
VDJ Recombinases | 2 | 2000 | 84 | 0.090 |
Why?
|
Cell Line | 7 | 2020 | 15601 | 0.090 |
Why?
|
Sural Nerve | 1 | 2010 | 105 | 0.090 |
Why?
|
History, 21st Century | 1 | 2016 | 1567 | 0.090 |
Why?
|
Leptin | 1 | 2018 | 1597 | 0.090 |
Why?
|
Oxidants | 1 | 2010 | 169 | 0.090 |
Why?
|
Treatment Outcome | 10 | 2024 | 64685 | 0.090 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 2 | 2000 | 111 | 0.080 |
Why?
|
Mitochondria | 2 | 2022 | 3624 | 0.080 |
Why?
|
Cysteine | 1 | 2014 | 891 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2735 | 0.080 |
Why?
|
Demyelinating Diseases | 1 | 2011 | 352 | 0.080 |
Why?
|
Drug Synergism | 2 | 2024 | 1757 | 0.080 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1420 | 0.080 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1784 | 0.080 |
Why?
|
Drug Interactions | 1 | 2013 | 1416 | 0.080 |
Why?
|
Exons | 1 | 2014 | 2391 | 0.080 |
Why?
|
History, 20th Century | 1 | 2016 | 2767 | 0.080 |
Why?
|
Clinical Trials as Topic | 3 | 2022 | 8002 | 0.080 |
Why?
|
Stem Cells | 1 | 2021 | 3524 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 615 | 0.080 |
Why?
|
Hepatocytes | 1 | 2015 | 1233 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 3 | 2019 | 17904 | 0.080 |
Why?
|
Phosphorylation | 3 | 2012 | 8321 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2023 | 6345 | 0.080 |
Why?
|
Chromosomes, Human, X | 1 | 2010 | 321 | 0.080 |
Why?
|
Peptide Library | 1 | 2009 | 347 | 0.070 |
Why?
|
X Chromosome Inactivation | 1 | 2010 | 227 | 0.070 |
Why?
|
Frontal Lobe | 1 | 2014 | 1420 | 0.070 |
Why?
|
Receptors, Androgen | 1 | 2014 | 1079 | 0.070 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 934 | 0.070 |
Why?
|
Salvage Therapy | 1 | 2014 | 1263 | 0.070 |
Why?
|
Carcinoma, Embryonal | 1 | 2007 | 37 | 0.070 |
Why?
|
Mice, Nude | 3 | 2020 | 3614 | 0.070 |
Why?
|
Blotting, Western | 1 | 2015 | 5035 | 0.070 |
Why?
|
Child, Preschool | 10 | 2023 | 42232 | 0.070 |
Why?
|
Skin Neoplasms | 2 | 2022 | 5821 | 0.070 |
Why?
|
Peptides, Cyclic | 1 | 2009 | 392 | 0.070 |
Why?
|
Hydrogen Peroxide | 1 | 2010 | 730 | 0.070 |
Why?
|
Oxidative Stress | 3 | 2019 | 3113 | 0.070 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2021 | 2547 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1898 | 0.070 |
Why?
|
Temporal Lobe | 1 | 2014 | 1695 | 0.070 |
Why?
|
World Health Organization | 2 | 2023 | 1322 | 0.070 |
Why?
|
Pilot Projects | 4 | 2024 | 8633 | 0.070 |
Why?
|
Pyridines | 2 | 2021 | 2875 | 0.070 |
Why?
|
Reproducibility of Results | 8 | 2022 | 20100 | 0.070 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2014 | 1520 | 0.070 |
Why?
|
Cell Cycle Proteins | 2 | 2019 | 3449 | 0.070 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2021 | 561 | 0.070 |
Why?
|
Parkinsonian Disorders | 1 | 2009 | 284 | 0.070 |
Why?
|
Seminoma | 1 | 2007 | 134 | 0.070 |
Why?
|
Radiography | 2 | 2014 | 6965 | 0.070 |
Why?
|
Mycosis Fungoides | 1 | 2007 | 170 | 0.070 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2012 | 436 | 0.060 |
Why?
|
Antigen Presentation | 2 | 2023 | 1251 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7593 | 0.060 |
Why?
|
Virus Replication | 1 | 2014 | 2435 | 0.060 |
Why?
|
Mutation, Missense | 2 | 2014 | 2571 | 0.060 |
Why?
|
Ear Canal | 1 | 2006 | 147 | 0.060 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2024 | 373 | 0.060 |
Why?
|
Dacarbazine | 1 | 2009 | 559 | 0.060 |
Why?
|
Receptors, Estrogen | 1 | 2014 | 2209 | 0.060 |
Why?
|
Neurosurgical Procedures | 1 | 2016 | 2072 | 0.060 |
Why?
|
Seizures | 3 | 2024 | 2957 | 0.060 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 1745 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1252 | 0.060 |
Why?
|
Combined Modality Therapy | 4 | 2023 | 8527 | 0.060 |
Why?
|
Carrier Proteins | 1 | 1998 | 4937 | 0.060 |
Why?
|
Brain Stem Neoplasms | 1 | 2006 | 190 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 2 | 2015 | 4062 | 0.060 |
Why?
|
Organ Specificity | 2 | 2024 | 1968 | 0.060 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6075 | 0.060 |
Why?
|
Hematopoiesis | 1 | 2014 | 2050 | 0.060 |
Why?
|
Gene Expression Regulation | 3 | 2014 | 11904 | 0.060 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2004 | 81 | 0.060 |
Why?
|
Hematologic Neoplasms | 1 | 2016 | 1896 | 0.060 |
Why?
|
Sensitivity and Specificity | 5 | 2013 | 14665 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2020 | 22176 | 0.060 |
Why?
|
Infant | 8 | 2023 | 36193 | 0.060 |
Why?
|
Alleles | 4 | 2018 | 6864 | 0.060 |
Why?
|
Gene Expression | 1 | 2016 | 7581 | 0.060 |
Why?
|
DNA Modification Methylases | 2 | 2018 | 210 | 0.060 |
Why?
|
Neuroprotective Agents | 1 | 2010 | 957 | 0.060 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2007 | 333 | 0.060 |
Why?
|
Alkaline Phosphatase | 1 | 2006 | 864 | 0.050 |
Why?
|
ARNTL Transcription Factors | 1 | 2024 | 96 | 0.050 |
Why?
|
Antigens, CD | 1 | 2014 | 4001 | 0.050 |
Why?
|
Receptors, AMPA | 1 | 2024 | 336 | 0.050 |
Why?
|
Craniotomy | 2 | 2019 | 741 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2019 | 988 | 0.050 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1600 | 0.050 |
Why?
|
Tissue Distribution | 2 | 2019 | 2264 | 0.050 |
Why?
|
Lymphocytes | 2 | 2001 | 2612 | 0.050 |
Why?
|
alpha-Synuclein | 1 | 2009 | 750 | 0.050 |
Why?
|
Pyrazoles | 1 | 2013 | 2009 | 0.050 |
Why?
|
DNA Repair Enzymes | 2 | 2018 | 346 | 0.050 |
Why?
|
Astrocytes | 1 | 2010 | 1346 | 0.050 |
Why?
|
Dihydrolipoyllysine-Residue Acetyltransferase | 1 | 2022 | 11 | 0.050 |
Why?
|
Microdissection | 1 | 2022 | 151 | 0.050 |
Why?
|
Antibody Specificity | 1 | 2004 | 1060 | 0.050 |
Why?
|
Gene Frequency | 2 | 2020 | 3606 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2020 | 2917 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2021 | 2898 | 0.050 |
Why?
|
Ionophores | 1 | 2022 | 107 | 0.050 |
Why?
|
Research Design | 1 | 2018 | 6180 | 0.050 |
Why?
|
Energy Metabolism | 1 | 2013 | 2882 | 0.050 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 186 | 0.050 |
Why?
|
Protein Binding | 5 | 2024 | 9353 | 0.050 |
Why?
|
Multiple Myeloma | 1 | 2020 | 5146 | 0.050 |
Why?
|
Hepatolenticular Degeneration | 1 | 2022 | 72 | 0.050 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2021 | 17 | 0.050 |
Why?
|
Iron-Sulfur Proteins | 1 | 2022 | 83 | 0.050 |
Why?
|
Flavobacterium | 1 | 2001 | 20 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 11122 | 0.050 |
Why?
|
Cell Membrane | 2 | 2021 | 3687 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 2 | 2001 | 3733 | 0.050 |
Why?
|
Phospholipase C beta | 1 | 2001 | 49 | 0.050 |
Why?
|
Immunophenotyping | 2 | 2024 | 1869 | 0.050 |
Why?
|
Receptor, Serotonin, 5-HT2C | 1 | 2001 | 42 | 0.050 |
Why?
|
Cell Respiration | 1 | 2022 | 201 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2022 | 411 | 0.050 |
Why?
|
Genetic Testing | 1 | 2014 | 3537 | 0.050 |
Why?
|
Receptors, CCR6 | 1 | 2021 | 74 | 0.050 |
Why?
|
Lipoylation | 1 | 2022 | 87 | 0.050 |
Why?
|
Immunoglobulin Joining Region | 1 | 2001 | 37 | 0.050 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2021 | 44 | 0.050 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 2001 | 166 | 0.050 |
Why?
|
Kinetics | 2 | 1999 | 6374 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2023 | 80647 | 0.050 |
Why?
|
Testicular Neoplasms | 1 | 2007 | 799 | 0.050 |
Why?
|
Receptors, Muscarinic | 1 | 2001 | 157 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7391 | 0.050 |
Why?
|
Cells, Cultured | 4 | 2019 | 18966 | 0.050 |
Why?
|
Calibration | 1 | 2023 | 818 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4514 | 0.040 |
Why?
|
Mammary Glands, Animal | 1 | 2022 | 273 | 0.040 |
Why?
|
Phosphatidylinositol Phosphates | 1 | 2001 | 201 | 0.040 |
Why?
|
Chemical Precipitation | 1 | 2000 | 175 | 0.040 |
Why?
|
Acrylonitrile | 1 | 2020 | 20 | 0.040 |
Why?
|
Repetitive Sequences, Amino Acid | 1 | 2000 | 92 | 0.040 |
Why?
|
Hydrazines | 1 | 2022 | 224 | 0.040 |
Why?
|
Receptors, Serotonin | 1 | 2001 | 208 | 0.040 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2001 | 147 | 0.040 |
Why?
|
Haplorhini | 1 | 2021 | 525 | 0.040 |
Why?
|
Cervical Vertebrae | 1 | 2006 | 980 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2019 | 3514 | 0.040 |
Why?
|
Caenorhabditis elegans | 1 | 2009 | 1456 | 0.040 |
Why?
|
Membrane Lipids | 1 | 2001 | 252 | 0.040 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2020 | 102 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2004 | 1069 | 0.040 |
Why?
|
Receptors, Antigen | 1 | 1999 | 51 | 0.040 |
Why?
|
Reference Standards | 1 | 2023 | 1003 | 0.040 |
Why?
|
Immunoglobulin Variable Region | 1 | 2001 | 419 | 0.040 |
Why?
|
Models, Genetic | 1 | 2009 | 3442 | 0.040 |
Why?
|
Transposases | 1 | 1999 | 104 | 0.040 |
Why?
|
Cell Line, Transformed | 1 | 2000 | 866 | 0.040 |
Why?
|
Endopeptidase Clp | 1 | 1999 | 42 | 0.040 |
Why?
|
Genome, Human | 3 | 2020 | 4425 | 0.040 |
Why?
|
Crystallography, X-Ray | 2 | 2001 | 1990 | 0.040 |
Why?
|
Cyclin D2 | 1 | 2019 | 98 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2022 | 328 | 0.040 |
Why?
|
Cell Death | 1 | 2024 | 1679 | 0.040 |
Why?
|
High Mobility Group Proteins | 1 | 1999 | 177 | 0.040 |
Why?
|
Random Allocation | 1 | 2023 | 2395 | 0.040 |
Why?
|
Sex Chromatin | 1 | 2018 | 19 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 2 | 2015 | 1115 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2015 | 12690 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2021 | 931 | 0.040 |
Why?
|
Genes, myc | 1 | 2020 | 390 | 0.040 |
Why?
|
RNA, Neoplasm | 2 | 2012 | 750 | 0.040 |
Why?
|
Atlases as Topic | 1 | 2020 | 248 | 0.040 |
Why?
|
Genes, BRCA2 | 1 | 2022 | 601 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2017 | 15936 | 0.040 |
Why?
|
Oxygen | 1 | 2010 | 4227 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 1 | 2009 | 2688 | 0.040 |
Why?
|
Protein Conformation | 3 | 2001 | 3968 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2020 | 332 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2009 | 3612 | 0.040 |
Why?
|
Integrases | 1 | 2001 | 518 | 0.040 |
Why?
|
Protein Transport | 1 | 2024 | 1967 | 0.040 |
Why?
|
Cluster Analysis | 2 | 2015 | 2707 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1136 | 0.040 |
Why?
|
Indazoles | 1 | 2020 | 304 | 0.040 |
Why?
|
Sequence Alignment | 2 | 1999 | 2180 | 0.040 |
Why?
|
Tryptophan | 1 | 2000 | 482 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12059 | 0.040 |
Why?
|
Genes, Recessive | 1 | 2000 | 623 | 0.040 |
Why?
|
Genes, BRCA1 | 1 | 2022 | 764 | 0.040 |
Why?
|
S Phase | 1 | 2019 | 421 | 0.040 |
Why?
|
Zinc Fingers | 1 | 2000 | 579 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 1999 | 361 | 0.040 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 1551 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2020 | 323 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2020 | 6214 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2020 | 784 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 976 | 0.040 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2018 | 350 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2022 | 789 | 0.040 |
Why?
|
Remission Induction | 1 | 2023 | 2397 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 698 | 0.040 |
Why?
|
Prospective Studies | 3 | 2023 | 54423 | 0.040 |
Why?
|
Quinazolines | 2 | 2014 | 1371 | 0.040 |
Why?
|
Mammals | 1 | 2022 | 1132 | 0.040 |
Why?
|
Endocytosis | 1 | 2021 | 957 | 0.030 |
Why?
|
Syndrome | 2 | 2000 | 3267 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2000 | 1163 | 0.030 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 428 | 0.030 |
Why?
|
Deoxycytidine | 1 | 2021 | 877 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2000 | 1693 | 0.030 |
Why?
|
Chromogranins | 1 | 2017 | 161 | 0.030 |
Why?
|
Japan | 1 | 2021 | 1378 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 695 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 1999 | 837 | 0.030 |
Why?
|
Phylogeny | 1 | 2024 | 2811 | 0.030 |
Why?
|
Isotretinoin | 1 | 2018 | 134 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2018 | 638 | 0.030 |
Why?
|
Etoposide | 1 | 2018 | 634 | 0.030 |
Why?
|
Prostatectomy | 1 | 2004 | 1824 | 0.030 |
Why?
|
Structure-Activity Relationship | 2 | 2014 | 3076 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2024 | 2206 | 0.030 |
Why?
|
Interferons | 1 | 2020 | 706 | 0.030 |
Why?
|
Eye Proteins | 1 | 1999 | 633 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1134 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1232 | 0.030 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2018 | 882 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 1999 | 902 | 0.030 |
Why?
|
Gene Fusion | 1 | 2018 | 356 | 0.030 |
Why?
|
Lysosomes | 1 | 2021 | 924 | 0.030 |
Why?
|
Testis | 1 | 1999 | 794 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2000 | 1739 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 266 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 959 | 0.030 |
Why?
|
Manganese | 1 | 1998 | 393 | 0.030 |
Why?
|
Gene Amplification | 1 | 2020 | 1089 | 0.030 |
Why?
|
Macrophages | 2 | 2020 | 5767 | 0.030 |
Why?
|
Vincristine | 1 | 2018 | 1036 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 2 | 2014 | 1974 | 0.030 |
Why?
|
Central Nervous System | 1 | 2022 | 1336 | 0.030 |
Why?
|
Organoids | 1 | 2021 | 746 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2012 | 22174 | 0.030 |
Why?
|
Magnesium | 1 | 1998 | 804 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2024 | 1906 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2020 | 1069 | 0.030 |
Why?
|
Withania | 1 | 2014 | 3 | 0.030 |
Why?
|
Microinjections | 1 | 2015 | 321 | 0.030 |
Why?
|
Oleic Acid | 1 | 2014 | 92 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2024 | 6312 | 0.030 |
Why?
|
Substrate Specificity | 2 | 2013 | 1791 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 303 | 0.030 |
Why?
|
Neurons | 2 | 2010 | 9463 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2022 | 3162 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 1999 | 1023 | 0.030 |
Why?
|
Hematoxylin | 1 | 2013 | 60 | 0.030 |
Why?
|
Skull Base | 1 | 2016 | 292 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 962 | 0.030 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2013 | 69 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 322 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 1999 | 4174 | 0.030 |
Why?
|
Recombinant Proteins | 2 | 2000 | 6534 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 1999 | 2065 | 0.030 |
Why?
|
Receptor, trkC | 1 | 2013 | 63 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2000 | 1265 | 0.030 |
Why?
|
Data Collection | 1 | 2022 | 3322 | 0.030 |
Why?
|
Plasmalogens | 1 | 2013 | 30 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 385 | 0.030 |
Why?
|
New Hampshire | 1 | 2013 | 175 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1814 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2019 | 1349 | 0.030 |
Why?
|
Leupeptins | 1 | 2012 | 113 | 0.030 |
Why?
|
United States | 2 | 2021 | 72340 | 0.030 |
Why?
|
Sulfhydryl Compounds | 1 | 2014 | 301 | 0.030 |
Why?
|
Genetic Variation | 2 | 2015 | 6567 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 454 | 0.030 |
Why?
|
Phosphotransferases | 1 | 2013 | 303 | 0.030 |
Why?
|
Color | 1 | 2013 | 299 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2013 | 315 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2024 | 2576 | 0.030 |
Why?
|
Escherichia coli Proteins | 1 | 1999 | 1067 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2015 | 945 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2018 | 2220 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 732 | 0.020 |
Why?
|
Disulfides | 1 | 2014 | 465 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2015 | 916 | 0.020 |
Why?
|
Phosphatidylinositols | 1 | 2013 | 282 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2019 | 888 | 0.020 |
Why?
|
Age of Onset | 1 | 2018 | 3306 | 0.020 |
Why?
|
Phosphatidylserines | 1 | 2013 | 188 | 0.020 |
Why?
|
Heme | 1 | 2013 | 313 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2015 | 1541 | 0.020 |
Why?
|
3T3 Cells | 1 | 2013 | 1085 | 0.020 |
Why?
|
Permeability | 1 | 2013 | 723 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2014 | 594 | 0.020 |
Why?
|
Macrolides | 1 | 2012 | 205 | 0.020 |
Why?
|
Piperidines | 1 | 2020 | 1656 | 0.020 |
Why?
|
Administration, Oral | 1 | 2019 | 4021 | 0.020 |
Why?
|
Transfection | 1 | 1999 | 5774 | 0.020 |
Why?
|
Models, Biological | 2 | 2012 | 9469 | 0.020 |
Why?
|
Pregnancy | 3 | 2022 | 29890 | 0.020 |
Why?
|
Rhodotorula | 1 | 2010 | 3 | 0.020 |
Why?
|
Cerebellum | 1 | 2018 | 1501 | 0.020 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2012 | 170 | 0.020 |
Why?
|
Homeostasis | 1 | 2022 | 3323 | 0.020 |
Why?
|
D-Amino-Acid Oxidase | 1 | 2010 | 26 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4281 | 0.020 |
Why?
|
Immunoblotting | 1 | 2014 | 1646 | 0.020 |
Why?
|
Lymph Nodes | 2 | 2015 | 3465 | 0.020 |
Why?
|
Specimen Handling | 1 | 2015 | 702 | 0.020 |
Why?
|
Piperazines | 1 | 2021 | 2523 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 1008 | 0.020 |
Why?
|
Rats | 2 | 2021 | 23741 | 0.020 |
Why?
|
Stereotaxic Techniques | 1 | 2013 | 555 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 2919 | 0.020 |
Why?
|
Freezing | 1 | 2011 | 311 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 1827 | 0.020 |
Why?
|
Electrodiagnosis | 1 | 2010 | 148 | 0.020 |
Why?
|
Multigene Family | 1 | 2013 | 1076 | 0.020 |
Why?
|
Risk Assessment | 2 | 2023 | 23996 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2020 | 26202 | 0.020 |
Why?
|
Charcot-Marie-Tooth Disease | 1 | 2010 | 100 | 0.020 |
Why?
|
Molecular Structure | 1 | 2014 | 1880 | 0.020 |
Why?
|
Imidazoles | 1 | 2015 | 1180 | 0.020 |
Why?
|
Autophagy | 1 | 2017 | 1327 | 0.020 |
Why?
|
Peptides | 1 | 2021 | 4358 | 0.020 |
Why?
|
Neural Conduction | 1 | 2010 | 441 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2022 | 4369 | 0.020 |
Why?
|
Mice, SCID | 1 | 2014 | 2626 | 0.020 |
Why?
|
DNA Helicases | 1 | 2014 | 851 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3384 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1590 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1188 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2019 | 2557 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2057 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1509 | 0.020 |
Why?
|
Karyotyping | 1 | 2010 | 1171 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2828 | 0.020 |
Why?
|
Glutathione | 1 | 2010 | 583 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1612 | 0.020 |
Why?
|
Codon | 1 | 2009 | 601 | 0.020 |
Why?
|
Brain | 4 | 2019 | 27121 | 0.020 |
Why?
|
Collagen | 1 | 2016 | 2638 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2000 | 5112 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 750 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2004 | 7859 | 0.020 |
Why?
|
Drug Design | 1 | 2012 | 1048 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2000 | 4758 | 0.020 |
Why?
|
Observer Variation | 1 | 2013 | 2606 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7396 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3511 | 0.020 |
Why?
|
Sirolimus | 1 | 2014 | 1533 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10554 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2014 | 1964 | 0.020 |
Why?
|
Fatty Acids | 1 | 2014 | 1808 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3779 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2010 | 1341 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2009 | 662 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15266 | 0.020 |
Why?
|
Drug Approval | 1 | 2013 | 814 | 0.020 |
Why?
|
Mastectomy | 1 | 2014 | 1822 | 0.020 |
Why?
|
Hot Temperature | 1 | 2012 | 1440 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6766 | 0.020 |
Why?
|
Protein Folding | 1 | 2009 | 870 | 0.020 |
Why?
|
DNA Primers | 1 | 2009 | 2820 | 0.020 |
Why?
|
Fever | 1 | 2013 | 1618 | 0.020 |
Why?
|
Headache | 1 | 2013 | 1256 | 0.010 |
Why?
|
Computational Biology | 1 | 2016 | 3517 | 0.010 |
Why?
|
Fibroblasts | 1 | 2014 | 4142 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2012 | 1745 | 0.010 |
Why?
|
Liver | 1 | 1999 | 7528 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3430 | 0.010 |
Why?
|
Pluripotent Stem Cells | 1 | 2010 | 799 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2013 | 2645 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13367 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8466 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2529 | 0.010 |
Why?
|
Binding Sites | 2 | 2001 | 6056 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6484 | 0.010 |
Why?
|
Cations, Divalent | 1 | 2001 | 168 | 0.010 |
Why?
|
Ultracentrifugation | 1 | 2001 | 183 | 0.010 |
Why?
|
Recombinases | 1 | 2001 | 67 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 2001 | 646 | 0.010 |
Why?
|
Models, Molecular | 2 | 2001 | 5439 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8833 | 0.010 |
Why?
|
Dimerization | 1 | 2001 | 891 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12463 | 0.010 |
Why?
|
Catalysis | 1 | 2001 | 774 | 0.010 |
Why?
|
Scattering, Radiation | 1 | 2001 | 490 | 0.010 |
Why?
|
Length of Stay | 1 | 2013 | 6426 | 0.010 |
Why?
|
Models, Statistical | 1 | 2013 | 5079 | 0.010 |
Why?
|
Molecular Weight | 1 | 2001 | 2186 | 0.010 |
Why?
|
Lymphopenia | 1 | 2001 | 281 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 2001 | 461 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2009 | 6815 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2014 | 5779 | 0.010 |
Why?
|
Clonal Anergy | 1 | 1998 | 169 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1999 | 1229 | 0.010 |
Why?
|
Risk Factors | 1 | 2023 | 74213 | 0.010 |
Why?
|
Family Health | 1 | 2001 | 1257 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2001 | 3597 | 0.010 |
Why?
|
Light | 1 | 2001 | 1353 | 0.010 |
Why?
|
Alternative Splicing | 1 | 1999 | 1093 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18255 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1999 | 1756 | 0.010 |
Why?
|
Eosinophilia | 1 | 1998 | 560 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2015 | 15633 | 0.010 |
Why?
|
Calcium | 1 | 2001 | 5722 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1998 | 5485 | 0.000 |
Why?
|
Databases, Factual | 1 | 2001 | 7968 | 0.000 |
Why?
|